Search
Displaying 31–40 of 1178 results
-
Tools and Techniques to Conquer the 4 Fears of Cooking with Vision Loss
- Feb 9, 2026
- 7:00 p.m. (EST)
- Virtual
Community EventJoin us for an exciting cooking session safely and independently.
-
- Jan 31, 2026
- 11:00 a.m. (MST)
- 515 N 51st Ave suite 130, Phoenix, AZ 85043
Community EventJoin the Foundation Fighting Blindness for Vision Connection, an enriching and supportive gathering for the blind and low vision community.
-
Triangle Chapter Lunch and Learn
- Jan 27, 2026
- 12:00 p.m. (EST)
- Virtual
Community EventVirtual Learning Event: North Carolina Division of Services for the Blind Resources
-
AAVantgarde Completes Enrollment in Retinal Gene Therapy Trial for Usher Syndrome Type 1B
Research NewsMilestone brings hope to patients with rare inherited retinal disease
-
Research News
First patient treated in Part B of ASTRA trial evaluating SB-007.
-
Eye on the Cure Podcast | Episode 98: Jonathan & Josh Steinberg
Eye on the CureJosh Steinberg and his father, Jon, talk with host Ben Shaberman about their close-knit family’s journey with Josh’s vision loss.
-
RD Fund Invests in Beacon Therapeutics to Advance XLRP Gene Therapy
Research NewsThe venture philanthropy arm of the Foundation partnered with other investors to support the development of a gene therapy trial for X-linked retinitis pigmentosa (XLRP).
-
Recording Available: Insights Forum | Friday, December 12, 2025
Foundation NewsThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on December 12, 2025.
-
Sight Enthusiast Alliance (SEA) by the Bay
The Bay Area Phorum provides a platform for professionals serving the blind and low vision community in San Francisco and surrounding areas to showcase services and other resources.
-
Eye on the Cure Podcast | Episode 97: Lindsey Rambo
Eye on the CureA mom, wife, and a special education teaching assistant, Lindsey is the first participant in a groundbreaking gene therapy trial for Leber congenital amaurosis (LCA5).
